tradingkey.logo

Retractable Technologies Inc

RVP
0.656USD
+0.006+0.91%
收盤 02/09, 16:00美東報價延遲15分鐘
16.61M總市值
虧損本益比TTM

Retractable Technologies Inc

0.656
+0.006+0.91%

關於 Retractable Technologies Inc 公司

Retractable Technologies, Inc. is engaged in the manufacturing and marketing of safety medical products (predominately syringes) for the healthcare industry. The Company is focused on the production of injection devices (syringes and needles). Such products are marketed under the VanishPoint, Patient Safe, and EasyPoint brands. The VanishPoint syringe, blood collection, and IV catheter products are designed to prevent needlestick injuries and product reuse by retracting the needle directly from the patient, effectively reducing exposure to the contaminated needle. Patient Safe syringes are designed to reduce the risk of bloodstream infections resulting from catheter hub contamination. The EasyPoint is a retractable needle that can be used with luer lock syringes, luer slip syringes, and prefilled syringes to give injections. The EasyPoint needle can also be used to aspirate fluids and for blood collection. Its products are distributed by various specialty and general line distributors.

Retractable Technologies Inc簡介

公司代碼RVP
公司名稱Retractable Technologies Inc
上市日期May 04, 2001
CEOShaw (Thomas J)
員工數量221
證券類型Ordinary Share
年結日May 04
公司地址511 Lobo Lane
城市LITTLE ELM
上市交易所NASDAQ OMX – NASDAQ Basic Amex
國家United States of America
郵編75068-0009
電話19722941010
網址https://retractable.com/
公司代碼RVP
上市日期May 04, 2001
CEOShaw (Thomas J)

Retractable Technologies Inc公司高管

名稱
名稱/職務
職務
持股
持股變動
Mr. Thomas J. Shaw
Mr. Thomas J. Shaw
Chairman of the Board, President, Chief Executive Officer, Founder
Chairman of the Board, President, Chief Executive Officer, Founder
16.33M
+13331.00%
Mr. Marco Laterza, CPA
Mr. Marco Laterza, CPA
Independent Director
Independent Director
85.00K
--
Mr. Darren E. Findley
Mr. Darren E. Findley
Independent Director
Independent Director
4.20K
--
Ms. Michele M. Larios, J.D.
Ms. Michele M. Larios, J.D.
Vice President, General Counsel, Secretary
Vice President, General Counsel, Secretary
--
--
Ms. Amy Mack
Ms. Amy Mack
Independent Director
Independent Director
--
--
Mr. Walter O. Bigby, Jr.
Mr. Walter O. Bigby, Jr.
Independent Director
Independent Director
--
--
Mr. John W. Fort, III
Mr. John W. Fort, III
Chief Financial Officer, Vice President, Treasurer, Director
Chief Financial Officer, Vice President, Treasurer, Director
--
--
名稱
名稱/職務
職務
持股
持股變動
Mr. Thomas J. Shaw
Mr. Thomas J. Shaw
Chairman of the Board, President, Chief Executive Officer, Founder
Chairman of the Board, President, Chief Executive Officer, Founder
16.33M
+13331.00%
Mr. Marco Laterza, CPA
Mr. Marco Laterza, CPA
Independent Director
Independent Director
85.00K
--
Mr. Darren E. Findley
Mr. Darren E. Findley
Independent Director
Independent Director
4.20K
--
Ms. Michele M. Larios, J.D.
Ms. Michele M. Larios, J.D.
Vice President, General Counsel, Secretary
Vice President, General Counsel, Secretary
--
--
Ms. Amy Mack
Ms. Amy Mack
Independent Director
Independent Director
--
--
Mr. Walter O. Bigby, Jr.
Mr. Walter O. Bigby, Jr.
Independent Director
Independent Director
--
--

收入明細

單位: USD更新時間: 1月6日 週二
單位: USD更新時間: 1月6日 週二
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
業務USD
名稱
營收
佔比
Syringes
5.85M
57.98%
EasyPoint Needles
3.85M
38.21%
Blood Cllection Products
372.75K
3.70%
Other Products
11.46K
0.11%
地區USD
名稱
營收
佔比
United States
9.19M
91.09%
North and South America(excluding U.S)
549.80K
5.45%
Other International
348.35K
3.45%
業務
地區
業務USD
名稱
營收
佔比
Syringes
5.85M
57.98%
EasyPoint Needles
3.85M
38.21%
Blood Cllection Products
372.75K
3.70%
Other Products
11.46K
0.11%

股東統計

更新時間: 2月7日 週六
更新時間: 2月7日 週六
持股股東
股東類型
持股股東
持股股東
佔比
Shaw (Thomas J)
54.55%
Larios Michele Mitchell
2.88%
The Vanguard Group, Inc.
2.25%
Renaissance Technologies LLC
1.43%
Eversept Partners, LP
1.21%
其他
37.68%
持股股東
持股股東
佔比
Shaw (Thomas J)
54.55%
Larios Michele Mitchell
2.88%
The Vanguard Group, Inc.
2.25%
Renaissance Technologies LLC
1.43%
Eversept Partners, LP
1.21%
其他
37.68%
股東類型
持股股東
佔比
Individual Investor
58.12%
Investment Advisor
4.12%
Hedge Fund
3.07%
Investment Advisor/Hedge Fund
0.92%
Venture Capital
0.05%
Research Firm
0.04%
其他
33.67%

機構持股

更新時間: 1月1日 週四
更新時間: 1月1日 週四
報告期間
機構數
持股數
持股佔比
持股變動
2025Q4
62
2.46M
8.20%
+132.22K
2025Q3
63
2.10M
7.00%
-941.15K
2025Q2
76
19.64M
65.62%
-749.70K
2025Q1
78
19.36M
64.67%
-761.97K
2024Q4
83
19.19M
64.11%
-1.01M
2024Q3
90
19.53M
65.24%
-827.36K
2024Q2
106
19.17M
64.04%
-1.44M
2024Q1
142
19.01M
63.51%
-2.11M
2023Q4
155
19.23M
64.23%
-1.87M
2023Q3
169
20.44M
68.26%
-2.39M
查看更多

股東持股明細

名稱
持股數
佔比
持股變動
變動比例
公告日期
Shaw (Thomas J)
16.33M
54.55%
+13.33K
+0.08%
Nov 14, 2025
Larios Michele Mitchell
861.00K
2.88%
--
--
Mar 10, 2025
The Vanguard Group, Inc.
672.81K
2.25%
-1.00K
-0.15%
Sep 30, 2025
Renaissance Technologies LLC
427.56K
1.43%
+79.16K
+22.72%
Sep 30, 2025
Eversept Partners, LP
363.31K
1.21%
+363.31K
--
Sep 30, 2025
BlackRock Institutional Trust Company, N.A.
241.12K
0.81%
-4.03K
-1.64%
Sep 30, 2025
Geode Capital Management, L.L.C.
128.11K
0.43%
--
--
Sep 30, 2025
Bridgeway Capital Management, LLC
88.54K
0.3%
-67.09K
-43.11%
Sep 30, 2025
Laterza (Marco)
85.00K
0.28%
--
--
Mar 10, 2025
Bigby (Walter O Jr)
80.00K
0.27%
--
--
Mar 10, 2025
查看更多

持股ETF

更新時間: 12月6日 週六
更新時間: 12月6日 週六
機構名稱
佔比
iShares Micro-Cap ETF
0%
iShares Micro-Cap ETF
佔比0%

分紅派息

近5年累計派現 0.00 美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
暫無數據

拆合股

公告日期
除權除息日
類型
比率
暫無數據
公告日期
除權除息日
類型
比率
暫無數據
KeyAI